Serum canine thymus and activation-regulated chemokine (TARC/CCL17) concentrations correlate with disease severity and therapeutic responses in dogs with atopic dermatitis.
Ryota AsahinaKazunori UedaYuri OshimaToshitaka KaneiMasahiro KatoMasutaka FurueToshihiro TsukuiMasahiko NagataSadatoshi MaedaPublished in: Veterinary dermatology (2020)
Serum TARC concentrations have potential as a clinical and research tool for the objective evaluation of disease severity and therapeutic responses for cAD.